Spiritual care for patients with COPD has rarely been discussed, and thus much remains unknown about their needs. The aims of this study were to identify the factors associated with spiritual well-being and to compare the levels of spiritual well-being between subjects with advanced COPD and those with inoperable lung cancer.
METHODS:
A total of 96 subjects with COPD or lung cancer participated in this study, which was conducted between December 2014 and April 2016. Measures included the Japanese version of the 12-item Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp-12) scale, the McGill Quality of Life Questionnaire (MQOL), the modified Medical Research Council (mMRC) dyspnea scale, and various other medico-social factors.
RESULTS:
No significant differences were found between subjects with COPD and those with lung cancer in median FACIT-Sp-12 scores (COPD, 27; lung cancer, 26; P = .81). However, significant differences were found in the 2 MQOL domains, suggesting that subjects with COPD had a better psychological state (P = .01) and that subjects with lung cancer had a better support state (P = .002). Multiple regression analysis revealed that mMRC was significantly associated with FACIT-Sp-12 scores in subjects with COPD.
CONCLUSIONS:
These results suggest that subjects with advanced COPD experience spiritual well-being similar to that of subjects with inoperable lung cancer.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, updated 2015. http://www.goldcopd.org. Accessed April 30, 2016.
2.
VestboJ, HurdSS, AgustíAG, JonesPW, VogelmeierC, AnzuetoA, et al. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2013; 187(4):347–365.
3.
AgustiA, CalverleyPM, CelliB, CoxsonHO, EdwardsLD, LomasDA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res, 2010; 11:122.
4.
HanMK, AgustiA, CalverleyPM, CelliBR, CrinerG, CurtisJL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med, 2010; 182(5):598–604.
5.
PuhanMA, Garcia-AymerichJ, FreyM, ter RietG, AntóJM, AgustíAG, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet, 2009; 374(9691):704–711.
6.
OgaT, TsukinoM, HajiroT, IkedaA, NishimuraK. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2011; 6:521–526.
7.
GottM, GardinerC, SmallN, PayneS, SeamarkD, BarnesS, et al. Barriers to advance care planning in chronic obstructive pulmonary disease. Palliat Med, 2009; 23(7):642–648.
8.
LuddingtonL, CoxS, HigginsonI, LivesleyB. The need for palliative care for patients with non-cancer diseases: a review of the evidence. Int J Palliat Nurs, 2001; 7(5):221–226.
9.
GoreJM, BrophyCJ, GreenstoneMA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax, 2000; 55(12):1000–1006.
10.
CellaDF, TulskyDS, GrayG, SarafianB, LinnE, BonomiA, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol, 1993; 11(3):570–579.
11.
PetermanAH, FitchettG, BradyMJ, HernandezL, CellaD. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy–Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med, 2002; 24(1):49–58.
12.
BradyMJ, PetermanAH, FitchettG, MoM, CellaD. A case for including spirituality in quality of life measurement in oncology. Psychooncology, 1999; 8(5):417–428.
13.
NoguchiW, OhnoT, MoritaS, AiharaO, TsujiiH, ShimozumaK, MatsushimaE. Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer. Support Care Cancer, 2004; 12(4):240–245.
14.
CohenSR, MountBM, StrobelMG, BuiF. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease: a preliminary study of validity and acceptability. Palliat Med, 1995; 9(3):207–219.
15.
CohenSR, MountBM, BrueraE, ProvostM, RoweJ, TongK. Validity of the McGill Quality of Life Questionnaire in the palliative care setting. A multi-center Canadian study demonstrating the importance of the existential domain. Palliat Med, 1997; 11(1):3–20.
16.
TsujikawaM, YokoyamaK, UrakawaK, OnishiK. Reliability and validity of Japanese version of the McGill Quality of Life Questionnaire assessed by application in palliative care wards. Palliat Med, 2009; 23(7):659–664.
17.
BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 1999; 54(7):581–586.
18.
KatsuraH, KanemaruA, YamadaK, MotegiT, WakabayashiR, KidaK. Long-term effectiveness of an inpatient pulmonary rehabilitation program for elderly COPD patients: comparison between young-elderly and old-elderly groups. Respirology, 9(2):230–236, 2004.
19.
HiratsukaT, KidaK. Quality of life measurements using a linear analog scale for elderly patients with chronic lung disease. Intern Med, 1993; 32(11):832–836.
20.
GoldstrawP, CrowleyJ, ChanskyK, GirouxDJ, GroomePA, Rami-PortaR, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol, 2007; 2(8):706–714.
21.
TemelJS, GreerJA, MuzikanskyA, GallagherER, AdmaneS, JacksonVA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 2010; 363(8):733–742.
22.
BakitasMA, TostesonTD, LiZ, LyonsKD, HullJG, LiZ, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol, 2015; 33(13):1438–1445.
23.
MoritaT, KawaM, HonkeY, KoharaH, MaeyamaE, KizawaY, et al. Existential concerns of terminally ill cancer patients receiving specialized palliative care in Japan. Support Care Cancer, 2004; 12(2):137–140.
24.
KawaharaM, TadaH, TokoroA, TeramukaiS, OrigasaH, KubotaK, et al. Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01). BMC Cancer, 2011; 11:356.
25.
AndoM, MoritaT, AkechiT, OkamotoT. Efficacy of short-term life-review interviews on the spiritual well-being of terminally ill cancer patients. J Pain Symptom Manage, 2010; 39(6):993–1002.
26.
BurtonAM, SautterJM, TulskyJA, LindquistJH, HaysJC, OlsenMK, et al. Burden and well-being among a diverse sample of cancer, congestive heart failure, and chronic obstructive pulmonary disease caregivers. J Pain Symptom Manage, 2012; 44(3):410–420.
27.
GoodridgeD, LawsonJ, DugglebyW, MarciniukD, RennieD, StangM. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med, 2008; 102(6):885–891.
28.
ChochinovHM, KristjansonLJ, BreitbartW, McClementS, HackTF, HassardT, HarlosM. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol, 2011; 12(8):753–762.
